Shuxuening Injection
Function and Efficacy
1. It has anti-myocardial ischemia effect. Ginkgo biloba total flavonoids can significantly reduce the total amplitude of abnormal ST segment elevation and the number of pathological Q waves in the electrocardiogram, inhibit the release of creatine phosphokinase in myocardial tissue, and reduce the scope of myocardial infarction. 2. It has anti-cerebral ischemia effect. Ginkgo biloba extract can promote the rapid recovery of ischemic cortical electroencephalogram, reduce the volume of cerebral infarction in rats with middle cerebral artery ischemia-reperfusion model caused by common carotid artery insertion, and significantly reduce the number of apoptotic cells. 3. It has anti-atherosclerosis effect. Ginkgo biloba extract can significantly reduce the percentage of aortic atherosclerotic plaque area, reduce plasma malondialdehyde (MDA) content and nitric oxide (NO) level. 4. It has anti-arrhythmic effect. Ginkgo biloba extract can increase the dose of ventricular premature beats, ventricular tachycardia, ventricular fibrillation and cardiac arrest induced by jugular vein injection of aconitine and barium chloride in rats, and shorten the action potential duration. 5. It has improved blood rheology. Ginkgo leaf extract can prolong the blood coagulation time of mice, inhibit the formation of blood fiber network, inhibit platelet aggregation induced by platelet activating factor in vitro, and promote the disaggregation of platelet aggregation induced by low concentration of PAF.
Ingredients
This product is a sterilized aqueous solution made from the extraction of ginkgo leaves. The auxiliary materials are sorbitol, % ethanol, methyl sulfoxide
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Ginkgo biloba extractIngredients |
1. It has anti-myocardial ischemia effect; 2. It has anti-cerebral ischemia effect; 3. It has anti-atherosclerosis effect; 4. It has anti-arrhythmia effect; 5. It has the effect of improving blood rheology. More |
90045-36-6 | 4 |
Appearance
This product is a yellow clear liquid.
Usage and Dosage
Intramuscular injection: 10 ml at a time, 1-2 times a day. Intravenous drip: 20 ml per day, diluted with 5% glucose injection to 250 ml or 500 ml, or as directed by a doctor.
Adverse Reactions
Allergic reactions are rare.
Precautions
1 Pregnant women are prohibited from using this product. 2 People who are allergic to this product and its ingredients. 3 During the acute attack of angina pectoris.
Special Population Medication
Precautions during pregnancy and lactation: Use with caution in pregnant women.
Drug Interactions
Not yet clear
Storage
Sealed and protected from light.
Packaging Specification
2ml per bottle
Validity Period
2 years.
Manufacturer
Shineway Pharmaceutical Group Ltd.
-
Founded in:
2003-12-30 -
Address:
No. 168, Shiluan Street, Luancheng District, Shijiazhuang City, Hebei Province -
Tax NO.:
91130000757518418T -
Registered Funds:
$136 million -
Website:
-
Email: